News | March 21, 2014

CE Marking Earned, First Implants Done of Boston Scientific Ingevity MRI Pacing Leads

Boston Scientific Ingevity Leads MRI Systems Pacemakers CRT EP Lab

March 21, 2014 — Boston Scientific Corp. received CE marking and launched in Europe the Ingevity family of magnetic resonance imaging (MRI) compatible pacing leads. The Ingevity family is a set of leads that can be placed using a 6 French introducer, including passive and active fixation models. Ingevity MRI pacing leads are part of the ImageReady MR-conditional pacemaker system, which includes Vitalio MRI, Formio MRI, Advantio MRI and Ingenio MRI pulse generators. When used with the Latitude NXT patient management system, these devices wirelessly monitor patients for conditions such as atrial arrhythmias.

The first implant of the Ingevity MRI lead was performed March 3 by Daniel Gras, M.D., at the Nouvelles Cliniques Nantaises in Nantes, France.

Other Boston Scientific CRM leads engineered for superior long-term clinical performance including the Reliance 4-Front defibrillation leads and the Acuity X4 CRT family of leads. One of the first implants of the Autogen X4 CRT-D system incorporating all three of these leads was performed by Gianluca Botto, head of cardiac electrophysiology and pacing at Sant'Anna Hospital in Como, Italy.

The subset of data from the Ingevity trial supporting CE marking demonstrates positive ratings on lead handling and maneuverability from 99.5 percent of implanters.

The Ingevity trial series includes prospective, non-randomized, multi-center, global clinical studies to support the Ingevity family of leads for CE marking, U.S. Food and Drug Administration (FDA) and other regulatory approvals. More than 1,600 patients have been implanted at 78 centers in 16 countries.

Ingevity MRI, Reliance 4-FRONT, Acuity X4, and Autogen X4 CRT-D are investigational devices and not available for sale in the United States. 

For more information: www.bostonscientific.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
GE Healthcxare Signa Pioneer MAGIC six contrasts in one scan software by SyntheticMR.

The MRI software enables several different contrasts to be obtained from one scan, shortening scan times.

Feature | Magnetic Resonance Imaging (MRI)| August 31, 2017
August 31, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for SyntheticMR’s SyMRI.
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
European Medicines Agency Issues Update on Gadolinium Contrast Agents
News | Contrast Media| August 29, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Overlay Init